View current and past issues of our Chapter newsletter.
4th Annual Rockin' Purple for Lupus Ride was a huge success!
Join the webinar on Wed., August 26
Results from a study of epratuzumab were recently released. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease.